Correlation Between Health and Bio Gene
Can any of the company-specific risk be diversified away by investing in both Health and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health and Plant and Bio Gene Technology, you can compare the effects of market volatilities on Health and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health and Bio Gene.
Diversification Opportunities for Health and Bio Gene
Pay attention - limited upside
The 3 months correlation between Health and Bio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Health and Plant and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health and Plant are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Health i.e., Health and Bio Gene go up and down completely randomly.
Pair Corralation between Health and Bio Gene
If you would invest 4.30 in Bio Gene Technology on November 6, 2024 and sell it today you would earn a total of 0.60 from holding Bio Gene Technology or generate 13.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Health and Plant vs. Bio Gene Technology
Performance |
| Timeline |
| Health and Plant |
| Bio Gene Technology |
Health and Bio Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Health and Bio Gene
The main advantage of trading using opposite Health and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.| Health vs. Advanced Braking Technology | Health vs. Computershare | Health vs. Flagship Investments | Health vs. Ras Technology Holdings |
| Bio Gene vs. Aussie Broadband | Bio Gene vs. Beam Communications Holdings | Bio Gene vs. Centrex Metals | Bio Gene vs. Mount Gibson Iron |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |